At @ months , the protocol reduced absolute RV pacing by a mean of @ % ( @ % CI @ % to @ % ) ( p < @ from baseline ) and resulted in a mean absolute improvement in LVEF of @ % ( @ % to @ % ) ( p < @ from baseline ) but no reduction in exercise capacity , NT-pro-BNP or quality of life .